Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Katsutaka Hashiba is active.

Publication


Featured researches published by Katsutaka Hashiba.


Journal of the American College of Cardiology | 2013

Association between gait speed as a measure of frailty and risk of cardiovascular events after myocardial infarction.

Yasushi Matsuzawa; Masaaki Konishi; Eiichi Akiyama; Hiroyuki Suzuki; Naoki Nakayama; Masayoshi Kiyokuni; Sumita S; Toshiaki Ebina; Masami Kosuge; Kiyoshi Hibi; Kengo Tsukahara; Noriaki Iwahashi; Mitsuaki Endo; Nobuhiko Maejima; Kenichiro Saka; Katsutaka Hashiba; Kozo Okada; Masataka Taguri; Satoshi Morita; Seigo Sugiyama; Hisao Ogawa; Hironobu Sashika; Satoshi Umemura; Kazuo Kimura

OBJECTIVES This study sought to determine the additional clinical value of gait speed to Framingham risk score (FRS), cardiac function, and comorbid conditions in predicting cardiovascular events in patients with ST-segment elevation myocardial infarction. BACKGROUND There is growing evidence that gait speed is inversely associated with all-cause mortality, particularly cardiovascular mortality, among the elderly. METHODS We undertook a single-center prospective observational study of gait speed in 472 patients with ST-segment elevation myocardial infarction in Japan, between 2001 and 2008. Gait speeds were measured using a 200-m course before discharge in all patients, and we followed up cardiovascular events, which consist of cardiovascular deaths, nonfatal myocardial infarctions, and nonfatal ischemic strokes. RESULTS During the 2,596 person-years of follow-up, 83 patients (17.6%) experienced cardiovascular events. Cardiovascular events increased across decreasing tertiles of gait speed (fastest tertile: n = 5, 3.2%; middle tertile: n = 20, 12.6%; slowest tertile, n = 58, 36.7%). By multiple adjusted Cox proportional hazards analysis, gait speed was a significant and independent predictor of cardiovascular events (hazard ratio for increasing 0.1 m/s of gait speed: 0.71, 95% confidence interval [CI]: 0.63 to 0.81, p < 0.001). The addition of gait speed to the model incorporating FRS, B-type natriuretic peptide levels, and comorbidity index improved reclassification (net reclassification index: 32.8%, 95% CI: 17.4 to 48.3, p < 0.001) and the C-statistics with a reasonable global fit and calibration (C-statistics: from 0.703 [95% CI: 0.636 to 0.763] to 0.786 [95% CI: 0.738 to 0.829]). CONCLUSIONS Among patients with ST-segment elevation myocardial infarction, slow gait speed was significantly associated with an increased risk of cardiovascular events. (Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction; NCT01484158).


Resuscitation | 2012

Percutaneous cardiopulmonary support in pulmonary embolism with cardiac arrest

Katsutaka Hashiba; Jun Okuda; Nobuhiko Maejima; Noriaki Iwahashi; Kengo Tsukahara; Yoshio Tahara; Kiyoshi Hibi; Masami Kosuge; Toshiaki Ebina; Satoshi Umemura; Kazuo Kimura

OBJECTIVE To assess the role of percutaneous cardiopulmonary support (PCPS) for the resuscitation of patients with massive pulmonary embolism (PE) with circulatory collapse. We also compared outcomes for PCPS between patients with massive PE with circulatory collapse and patients with AMI with cardiogenic shock. BACKGROUND The effectiveness of PCPS for acute myocardial infarction (AMI) complicated with cardiogenic shock has been reported, but there are few reports on the use of PCPS for massive PE with circulatory collapse. METHOD We studied 12 consecutive patients with massive PE and 16 patients with AMI, who required PCPS for resuscitation either during cardiopulmonary resuscitation (CPR) or after successful CPR. RESULTS Twelve patients with PE and 16 patients with AMI were identified. There were no differences in age, the Acute Physiology, Age and Chronic Health Evaluation II (APACHE II) score at admission, rate of cardiac arrest on arrival, and time from first circulatory collapse to PCPS between the two groups. However, the proportion of men with PE (33%) was smaller than those with AMI (87%, p<0.05). The duration of PCPS was shorter in PE (38 h) compared with AMI (83 h, p=0.051) patients. The proportion of patients successfully weaned from PCPS (100% vs. 37.5%, p<0.01), survival rate at discharge (83.3% vs. 12.5%, p<0.001) and good neurological outcome (58.3% vs. 6.3%, p=0.004) was significantly higher for PE compared to AMI patients. CONCLUSION In our small case series, percutaneous cardiopulmonary support (PCPS) had a life saving role in patients with massive PE and cardiac arrest. PCPS was also more effective in patients with massive PE with cardiac arrest than in patients with AMI and cardiac arrest.


Clinical Cardiology | 2008

Value of serial C-reactive protein measurements in non ST-segment elevation acute coronary syndromes.

Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Toshiyuki Ishikawa; Mitsuaki Endo; Takayuki Mitsuhashi; Katsutaka Hashiba; Satoshi Umemura; Kazuo Kimura

Elevated C‐reactive protein (CRP) levels at admission are associated with adverse outcomes in patients with non ST‐segment elevation acute coronary syndromes (NSTE‐ACS).


Journal of the American Heart Association | 2017

Prolonged Fever After ST‐Segment Elevation Myocardial Infarction and Long‐Term Cardiac Outcomes

Chika Kawashima; Yasushi Matsuzawa; Eiichi Akiyama; Masaaki Konishi; Hiroyuki Suzuki; Katsutaka Hashiba; Toshiaki Ebina; Masami Kosuge; Kiyoshi Hibi; Kengo Tsukahara; Noriaki Iwahashi; Nobuhiko Maejima; Kentaro Sakamaki; Satoshi Umemura; Kazuo Kimura; Kouichi Tamura

Background The biphasic inflammation after ST‐segment elevation myocardial infarction (STEMI) plays an important role in myocardial healing and progression of systemic atherosclerosis. The purpose of this study is to investigate the impact of fever during the first and second phases of post‐STEMI inflammation on long‐term cardiac outcomes. Methods and Results A total of 550 patients with STEMI were enrolled in this study. Axillary body temperature (BT) was measured and maximum BTs were determined for the first (within 3 days: max‐BT 1–3d) and second (from 4 to 10 days after admission: max‐BT 4–10d) phases, respectively. Patients were followed for cardiac events (cardiovascular death, acute coronary syndrome, and rehospitalization for heart failure) for a median 5.3 years. During the follow‐up period, 80 patients experienced cardiac events. A high max‐BT 4–10d was strongly associated with long‐term cardiac events (hazard ratio, 95% CI) for a 1°C increase in the max‐BT 4–10d: 2.834 (2.017–3.828), P<0.0001, whereas the max‐BT 1–3d was not associated with cardiac events (1.136 [0.731–1.742], P=0.57). Even after adjustment for coronary risk factors, estimated glomerular filtration rate, infarct size, pericardial effusion, and medications on discharge, fever during the second phase (max‐BT 4–10d ≥37.1°C) was significantly associated with future cardiac events (hazard ratio [95% CI] 2.900 [1.710–5.143], P<0.0001). Conclusions Fever during the second phase but not the first phase of post‐STEMI inflammation was a strong associated factor with worse long‐term cardiac outcomes in patients after STEMI, suggesting the need to consider the optimal timing for anti‐inflammatory strategies after STEMI.


Journal of the American College of Cardiology | 2017

ASSOCIATION BETWEEN PRESENTATION TIME AND SHORT-TERM MORTALITY IN PATIENTS WITH CARDIOGENIC SHOCK COMPLICATING ACUTE CORONARY SYNDROME: FROM JCS SHOCK REGISTRY

Taketo Sonoda; Manabu Ogita; Tetsuya Matoba; Masahiro Mohri; Nobuhiro Tanaka; Yohei Hokama; Motoki Fukutomi; Katsutaka Hashiba; Rei Fukuhara; Yasushi Ueki; Hirohide Matsuura; Satoru Suwa; Eizo Tachibana; Naohiro Yonemoto; Ken Nagao

Introduction: Several studies have shown that patients with acute coronary syndrome (ACS) presenting during off-hours have higher mortality, however, the impact of off-hour presentation on short-term mortality in patients with cardiogenic shock complicating ACS is uncertain. Hypothesis: Off-hour presentation may affect the short-term mortality in ACS patients with cardiogenic shock. Methods: We investigated consecutive 499 patients with cardiogenic shock complicating ACS from prospective and national-wide multicenter registry (JCS Shock Registry) database from March 2012 to April 2014. The primary outcomes of the present study were 30-day mortality among patients presenting either during regular-hours (defined as week-day from 8:00 AM to 8:00 PM) and off-hour (defined as weekdays from 8:01 PM to 7:59 AM, weekends and holidays). Results: Fifty-three percent of patients were presented in off-hour. Baseline characteristics were comparable including symptom onset to presentation time (off-hour; 65 min, interquartile range 39 to 180 vs. regular hour; 59 min, interquartile range 38 to 143, p = 0.22). Eighty percent of patients underwent urgent percutaneous coronary intervention and door to balloon time was also comparable between groups (off-hour; 86 min, interquartile range 60 to 110 vs. regular hour; 80 min, interquartile range 60 to 110, p = 0.74). The rate of 30-day mortality were comparable (off-hour; 35.1 % vs. regular hour 31.7 %, log-rank p = 0.48). In multivariate cox regression analysis, off-hours presentation did not affect the 30-day mortality (age- and gender-adjusted HR 1.12, 95% CI 0.82-1.52, p = 0.46). Conclusions: The clinical impact of either off-hours or regular-hours presentation is comparable in patients with cardiogenic shock complicating acute coronary syndrome (ACS) in Japan.


Journal of the American College of Cardiology | 2016

RELATIONSHIP BETWEEN THICKNESS OF CALCIUM AND CRACK FORMATION AFTER BALLOON DILATATION IN CALCIFIED PLAQUE REQUIRING ROTATIONAL ATHERECTOMY: SERIAL OPTICAL COHERENCE TOMOGRAPHY STUDY

Nobuhiko Maejima; Kiyoshi Hibi; Shotaro Kuji; Kensuke Matsushita; Yugo Minamimoto; Eiichi Akiyama; Yasushi Matsuzawa; Katsutaka Hashiba; Noriaki Iwahashi; Kengo Tsukahara; Masami Kosuge; Toshiaki Ebina; Satoshi Umemura; Kazuo Kimura

Target lesion calcification is known to influence the results of percutaneous coronary intervention. Rotational atherectomy (RA) plays an important role to facilitate the dilation or stenting of these lesions. The aim of this study was to assess the incidence of calcium crack after balloon


Circulation | 2008

C-Reactive Protein Elevation and Rapid Angiographic Progression of Nonculprit Lesion in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome

Tatsuya Nakachi; Masami Kosuge; Kiyoshi Hibi; Toshiaki Ebina; Katsutaka Hashiba; Takayuki Mitsuhashi; Mitsuaki Endo; Satoshi Umemura; Kazuo Kimura


Circulation | 2010

Impact of High-Responsiveness to Dual Antiplatelet Therapy on Bleeding Complications in Patients Receiving Drug-Eluting Stents

Kengo Tsukahara; Kazuo Kimura; Satoshi Morita; Toshiaki Ebina; Masami Kosuge; Kiyoshi Hibi; Jun Okuda; Noriaki Iwahashi; Nobuhiko Maejima; Tatsuya Nakachi; Fumiyuki Ohtsuka; Katsutaka Hashiba; Yoshio Tahara; Teruyasu Sugano; Satoshi Umemura


Japanese Circulation Journal-english Edition | 2009

PJ-247 Early, Simple, Noninvasive Predictors of Left Main or 3-Vessel Disease in Patients with Non-ST-segment Elevation Acute Coronary Syndromes(PJ042,ACS/AMI (Clinical/Diagnosis) 1 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)

Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Jun Okuda; Noriaki Iwahashi; Kengo Tukahara; Takayuki Mitsuhashi; Katsutaka Hashiba; Fumiyuki Ohtsuka; Naohiro Komura; Naoki Nakayama; Yoshio Tahara; Kazutoshi Minami; Masayoshi Kiyokuni; Nobuhiko Maejima; Tatsuya Nakachi; Satoshi Umemura; Kazuo Kimura


Circulation | 2009

Early, Accurate, Non-Invasive Predictors of Left Main or 3-Vessel Disease in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome

Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Satoshi Morita; Naohiro Komura; Katsutaka Hashiba; Masayoshi Kiyokuni; Naoki Nakayama; Satoshi Umemura; Kazuo Kimura

Collaboration


Dive into the Katsutaka Hashiba's collaboration.

Top Co-Authors

Avatar

Kazuo Kimura

Yokohama City University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Toshiaki Ebina

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

Kiyoshi Hibi

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

Masami Kosuge

Yokohama City University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Noriaki Iwahashi

Yokohama City University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Jun Okuda

Yokohama City University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masayoshi Kiyokuni

Yokohama City University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge